Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

498
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
498
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.0K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

1.8K
The pathophysiology of pneumonia involves the following steps:
1.8K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

603
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
603
Pneumonia IV: Management01:28

Pneumonia IV: Management

583
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
583
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.2K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meningococcal carriage and transmission dynamics in college students in Louisville, Kentucky.

PloS one·2026
Same author

Rehab and Death: Improving End-Of-Life Care for Medicare Skilled Nursing Facility Beneficiaries.

Journal of the American Geriatrics Society·2025
Same author

Actinomyces in the Bloodstream: A Pathogen or Passenger?

Cureus·2025
Same author

Vancomycin-Induced Severe Neutropenia in a Patient With Osteomyelitis: A Case Report.

Cureus·2025
Same author

Long-term Effects of COVID-19 on Vascular Parameters-A Prospective Longitudinal Ultrasound Clinical Study.

Journal for vascular ultrasound : JVU·2024
Same author

Association between echocardiographic features, troponin levels, and survival time in hospitalized COVID-19 patients with cardiovascular events.

Journal of anesthesia and translational medicine·2024

Related Experiment Video

Updated: Nov 20, 2025

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.8K

Pneumonia in older adults.

Christian Davis Furman1,2,3, Angela Leinenbach1,4, Ronnita Usher1,2,3

  • 1Trager Institute.

Current Opinion in Infectious Diseases
|January 20, 2021
PubMed
Summary

Community-acquired pneumonia (CAP) affects over a million older adults annually in the US. Addressing viral CAP and racial disparities is crucial for improving outcomes in this vulnerable population.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.7K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.3K

Related Experiment Videos

Last Updated: Nov 20, 2025

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.8K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.7K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.3K

Area of Science:

  • Geriatrics
  • Infectious Diseases
  • Public Health

Background:

  • Community-acquired pneumonia (CAP) is a significant health concern for older adults.
  • The incidence of CAP in adults over 65 in the US is substantial, exceeding one million cases annually.
  • Older adults face unique vulnerabilities, including increased susceptibility to viral CAP and persistent racial disparities.

Purpose of the Study:

  • To review current issues concerning community-acquired pneumonia (CAP) in older adults.
  • To highlight evolving epidemiological trends and etiological factors of CAP in this demographic.
  • To discuss disparities and outcomes related to CAP in the elderly population.

Main Methods:

  • This review synthesizes recent findings on CAP epidemiology in older adults.
  • It incorporates data from studies utilizing traditional culture methods and novel microbiological techniques.
  • Analysis includes consideration of racial disparities and comorbidities impacting CAP severity.

Main Results:

  • The epidemiology of CAP in older adults is dynamic, with increasing recognition of viral causes like SARS-CoV-2.
  • Streptococcus pneumoniae remains the most frequent bacterial pathogen.
  • Racial disparities, particularly affecting African-Americans, are linked to higher comorbidity rates and potentially more severe CAP, though in-hospital outcomes between races may be similar.

Conclusions:

  • Outcomes for older adults with CAP are generally worse compared to younger adults.
  • Addressing racial disparities is essential for improving both early and long-term outcomes.
  • The economic burden of CAP is considerable, comparable to other major chronic conditions.